Close Menu

NEW YORK (GenomeWeb) – SpeeDx, an Australia-based manufacturer of diagnostic test kits, announced today that it has expanded its footprint in the Middle East through a new distribution partnership.

The partnership with Al Zahrawi Medical Supplies will enable distribution of the firm's SpeeDx Resistance Plus and PlexPCR portfolios in the United Arab Emirates, Saudi Arabia, Bahrain, Qatar, and Oman.

The SpeeDx ResistancePlus tests combine infection detection with detection of genetic markers of antibiotic resistance.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.